AI assistant
Upstream Bio, Inc. — Director's Dealing 2024
Oct 11, 2024
32187_dirs_2024-10-10_11bcb205-04cb-44fd-ae4c-8c9a5a09ce5b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Upstream Bio, Inc. (UPB)
CIK: 0002022626
Period of Report: 2024-10-10
Reporting Person: Ruddy Marcella K. (N/A)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.45 | 2032-07-02 | Common Stock (13159) | Direct | |
| Stock Option (Right to Buy) | $4.27 | 2033-03-02 | Common Stock (43115) | Direct | |
| Stock Option (Right to Buy) | $4.87 | 2033-08-13 | Common Stock (7867) | Direct |
Footnotes
F1: The shares underlying this option vest in forty-eight equal monthly installments following July 3, 2022, subject to the Reporting Person's continued service on each such vesting date.
F2: 25% of the shares underlying this option vested on March 3, 2024, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F3: 25% of the shares underlying this option vested on August 10, 2024, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.